Show simple item record

dc.contributor.authorBöckerman, Petri
dc.contributor.authorHaapanen, Mika
dc.contributor.authorHakulinen, Christian
dc.contributor.authorKarhunen, Hannu
dc.contributor.authorMaczulskij, Terhi
dc.date.accessioned2021-01-14T13:48:48Z
dc.date.available2021-01-14T13:48:48Z
dc.date.issued2021
dc.identifier.citationBöckerman, P., Haapanen, M., Hakulinen, C., Karhunen, H., & Maczulskij, T. (2021). Determinants of Prescription Opioid Use : Population‐Based Evidence from Finland. <i>Addiction</i>, <i>116</i>(1), 170-175. <a href="https://doi.org/10.1111/add.15071" target="_blank">https://doi.org/10.1111/add.15071</a>
dc.identifier.otherCONVID_35208046
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/73623
dc.description.abstractBackground and aims Previous studies have shown that prescription opioid use is more common in the socioeconomically disadvantaged communities in the US. This study examined the area and individual‐level determinants of prescription opioid use in Finland during the period 1995‐2016. Design Logistic regression analysis using nationwide data on filled opioid‐related prescriptions dispensed at Finnish pharmacies and covered by the National Health Insurance. Opioid consumption was linked, using personal identification codes, to population‐based data maintained by Statistics Finland, which records individual background and area‐level characteristics. Setting and participants Working‐age population aged between 15 and 64 years in Finland during the periods 1995‐2007 (n = 4 315 409) and 2009‐2016 (n = 4 116 992). Measurements Annual prescription opioid use was measured using defined daily doses (DDD) and whether individuals used opioids during a year. Findings Prescription opioid use increased in Finland from 1995 to 2016 (from less than 1% to 7%), but the increase was explained by the change in the treatment of codeine‐based opioids in the National Health Insurance. The area‐level unemployment rate was positively correlated with the share of opioid users at the municipal level (r = 0.36; p < 0.001). In comparison with being employed, being outside the labour force was associated with increased opioid use in 1995‐2007 (OR 2.22, 95% CI 2.10‐2.36) and non‐codeine opioid use in 2009‐2016 (OR 2.16, 95% CI 2.06‐2.27), but not with codeine opioid use in 2009‐2016. Conclusions Prescription opioid use in Finland appears to be more common among low‐socioeconomic status individuals, similar to the US and the UK.en
dc.format.mimetypeapplication/pdf
dc.languageeng
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofseriesAddiction
dc.rightsCC BY-NC 4.0
dc.subject.otheropioids
dc.subject.otheropioid use
dc.subject.othercodeine
dc.subject.otherprescription drugs
dc.subject.otherprevalence
dc.subject.otherpopulation‐based
dc.subject.othersocioeconomic status
dc.subject.otherFinland
dc.titleDeterminants of Prescription Opioid Use : Population‐Based Evidence from Finland
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202101141099
dc.contributor.laitosKauppakorkeakoulufi
dc.contributor.laitosSchool of Business and Economicsen
dc.contributor.oppiaineTaloustiedefi
dc.contributor.oppiainePäätöksentekoa tukeva taloustiede ja talouden kilpailukyky (painoala)fi
dc.contributor.oppiaineEmpirical Microeconomicsfi
dc.contributor.oppiaineBasic or discovery scholarshipfi
dc.contributor.oppiaineEconomicsen
dc.contributor.oppiainePolicy-Relevant Economics and Competitiveness of Economy (focus area)en
dc.contributor.oppiaineEmpirical Microeconomicsen
dc.contributor.oppiaineBasic or discovery scholarshipen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.description.reviewstatuspeerReviewed
dc.format.pagerange170-175
dc.relation.issn0965-2140
dc.relation.numberinseries1
dc.relation.volume116
dc.type.versionpublishedVersion
dc.rights.copyright© 2020 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction
dc.rights.accesslevelopenAccessfi
dc.relation.grantnumber6621
dc.subject.ysoväestötutkimus
dc.subject.ysokäyttö
dc.subject.ysoopioidit
dc.subject.ysososioekonomiset tekijät
dc.subject.ysolääkemääräykset
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p11417
jyx.subject.urihttp://www.yso.fi/onto/yso/p1736
jyx.subject.urihttp://www.yso.fi/onto/yso/p6030
jyx.subject.urihttp://www.yso.fi/onto/yso/p2134
jyx.subject.urihttp://www.yso.fi/onto/yso/p5840
dc.rights.urlhttps://creativecommons.org/licenses/by-nc/4.0/
dc.relation.doi10.1111/add.15071
dc.relation.funderYrjö Jahnssonin säätiöfi
dc.relation.funderYrjö Jahnsson Foundationen
jyx.fundinginformationFunding from the Academy of Finland (310591 to CH) and OP Group Research Foundation (to MH) and Yrjö Jahnsson Foundation (6621 to MH) is acknowledged.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY-NC 4.0
Except where otherwise noted, this item's license is described as CC BY-NC 4.0